Clinical Microbiomics

Clinical Microbiomics, founded in 2016 and based in Denmark, is a pioneering company with a commitment encapsulated in its slogan, "Let's find the answers." The company is focused on delving into the intricacies of the microbiome, the human body's internal ecosystem, to unearth the connections between its dynamics and human health. Through a multidisciplinary approach, Clinical Microbiomics aims to decipher the complex mechanisms at play in health and disease.

Identifying and comprehending these intricate mechanisms requires an interdisciplinary approach, and Clinical Microbiomics stands at the forefront of this field, generating groundbreaking bioinformatics tools and analytical concepts. These innovations are setting new standards for understanding and influencing the microbiome, showcasing the company's dedication to pioneering advancements in microbiome science.

One of Clinical Microbiomics' key strengths lies in its collaborative efforts with globally renowned academic institutions, as well as leading biotech, consumer health, and pharmaceutical companies. Acting as an extension of their research organizations, the company forges connections, conducts in-depth analyses, and strives to connect the dots crucial for shaping the understanding of health and disease.

The most recent investment milestone for Clinical Microbiomics occurred on 11 October 2022, with a $10.00M Venture Round investment led by Seventure Partners. This injection of funds signifies the confidence that prominent investors have in the company's vision and capabilities, underlining Clinical Microbiomics' potential to drive significant developments in the field of microbiome science.